Mannkind reported $20.57M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adma Biologics ADMA:US $ 146.07M 6.93M
Biocryst Pharmaceuticals BCRX:US $ 23.38M 7.23M
ChemoCentryx CCXI:US 5.47M 2.58M
Dynavax Technologies DVAX:US $ 73.98M 5.06M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Halozyme Therapeutics HALO:US $ 97.62M 49.85M
JAZZ PHA JAZZ:US $ 861.7M 123.75M
Karyopharm Therapeutics KPTI:US $ 3.47M 404K
Macrogenics MGNX:US $ 2.95M 1.65M
Mannkind MNKD:US $ 20.57M 12.53M
Novavax NVAX:US $ 256.3M 256.3M
Peregrine Pharmaceuticals PPHM:US $ 30.35M 4.29M